AU2504188A - Novel intermediates of cephalosporin derivatives - Google Patents

Novel intermediates of cephalosporin derivatives

Info

Publication number
AU2504188A
AU2504188A AU25041/88A AU2504188A AU2504188A AU 2504188 A AU2504188 A AU 2504188A AU 25041/88 A AU25041/88 A AU 25041/88A AU 2504188 A AU2504188 A AU 2504188A AU 2504188 A AU2504188 A AU 2504188A
Authority
AU
Australia
Prior art keywords
novel intermediates
cephalosporin derivatives
cephalosporin
derivatives
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU25041/88A
Other versions
AU610278B2 (en
Inventor
Takayuki Naito
Masahisa Oka
Jun Okumura
Haruhiro Yamashita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of AU2504188A publication Critical patent/AU2504188A/en
Application granted granted Critical
Publication of AU610278B2 publication Critical patent/AU610278B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C07C45/79—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU25041/88A 1984-04-09 1988-11-11 Novel intermediates of cephalosporin derivatives Expired AU610278B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59794184A 1984-04-09 1984-04-09
US597941 1984-04-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU40862/85A Division AU580990B2 (en) 1984-04-09 1985-04-04 3-``3-(quaternaryammonio)-1-propen-1-yl``-3-cephem derivatives

Publications (2)

Publication Number Publication Date
AU2504188A true AU2504188A (en) 1989-03-02
AU610278B2 AU610278B2 (en) 1991-05-16

Family

ID=24393575

Family Applications (2)

Application Number Title Priority Date Filing Date
AU40862/85A Expired AU580990B2 (en) 1984-04-09 1985-04-04 3-``3-(quaternaryammonio)-1-propen-1-yl``-3-cephem derivatives
AU25041/88A Expired AU610278B2 (en) 1984-04-09 1988-11-11 Novel intermediates of cephalosporin derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU40862/85A Expired AU580990B2 (en) 1984-04-09 1985-04-04 3-``3-(quaternaryammonio)-1-propen-1-yl``-3-cephem derivatives

Country Status (31)

Country Link
JP (4) JPS615084A (en)
KR (1) KR870002166B1 (en)
AR (1) AR244694A1 (en)
AT (1) AT388735B (en)
AU (2) AU580990B2 (en)
BE (1) BE902148A (en)
CA (3) CA1276929C (en)
CH (1) CH669197A5 (en)
DD (3) DD249024A5 (en)
DE (1) DE3512225A1 (en)
DK (1) DK155985A (en)
ES (4) ES8607318A1 (en)
FI (1) FI84830C (en)
FR (1) FR2563832B1 (en)
GB (3) GB2157293B (en)
GR (1) GR850883B (en)
HU (2) HU193750B (en)
IE (2) IE58408B1 (en)
IL (1) IL74826A (en)
IT (1) IT1190353B (en)
LU (1) LU85840A1 (en)
MY (1) MY101940A (en)
NL (1) NL192925C (en)
NZ (1) NZ211659A (en)
OA (1) OA07985A (en)
PT (1) PT80246B (en)
RU (1) RU2056425C1 (en)
SE (4) SE466205B (en)
SU (4) SU1375140A3 (en)
YU (2) YU46151B (en)
ZA (1) ZA852236B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61145186A (en) * 1984-12-20 1986-07-02 Meiji Seika Kaisha Ltd Novel cephem compound and preparation thereof
US4708955A (en) * 1985-06-24 1987-11-24 Bristol-Myers Company 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
DE3650157T2 (en) * 1985-12-26 1995-05-04 Eisai Co Ltd CEPHALOSPORINE COMPOUNDS.
AU614723B2 (en) * 1986-10-13 1991-09-12 Eisai Co. Ltd. 3-propenylcephem derivative
IL84128A (en) * 1986-10-13 1992-12-01 Eisai Co Ltd 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them
JPH085897B2 (en) * 1986-11-06 1996-01-24 エーザイ株式会社 3-propenyl cephem derivative
FR2622585B1 (en) * 1987-11-03 1991-04-19 Roussel Uclaf NOVEL CEPHALOSPORINS COMPRISING IN POSITION 3 A SUBSTITUTED VINYL RADICAL, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS, THE COMPOSITIONS CONTAINING THEM AND THE NEW INTERMEDIATES OBTAINED
JPH0699449B2 (en) * 1988-03-16 1994-12-07 エーザイ株式会社 Synthetic intermediate of cephem derivative
EP0612751A3 (en) * 1988-03-16 1994-09-21 Eisai Co Ltd Compounds for the preparation of cephem derivatives.
FR2655042B1 (en) * 1989-11-29 1994-01-21 Adir Cie NOVEL SUBSTITUTED BENZOTHIAZOLINONES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2663332B1 (en) * 1990-06-15 1997-11-07 Roussel Uclaf NOVEL CEPHALOSPORINS COMPRISING IN POSITION 3 A RADICAL PROPENYL SUBSTITUTED BY A QUATERNARY AMMONIUM, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS, THE COMPOSITIONS CONTAINING THEM AND THE NEW INTERMEDIATES OBTAINED.
US5126336A (en) * 1990-08-23 1992-06-30 Bristol-Myers Squibb Company Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof
AT396108B (en) * 1991-08-21 1993-06-25 Biochemie Gmbh NEW PROCESS AND NEW INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF 7-AMINOCEPHALOSPORANIC ACID DERIVATIVES
JPH0741484A (en) * 1993-07-29 1995-02-10 Katayama Seiyakushiyo:Kk Cephem compound and antimicrobial agent
US5661144A (en) * 1994-08-16 1997-08-26 Meiji Seika Kabushiki Kaisha Cephem derivatives with 3-substituted bis heterocycles
PL345266A1 (en) 1998-06-22 2001-12-03 Hoffmann La Roche Propenyl cephalosporin derivatives
EP1666483B1 (en) 2003-09-09 2011-08-17 Nippon Chemical Industrial Company Limited Process for producing 3-chloromethyl-3-cephem derivative

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1342241A (en) * 1970-01-23 1974-01-03 Glaxo Lab Ltd Cephalosporin compounds
US4390534A (en) * 1978-12-29 1983-06-28 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
EP0025017A1 (en) * 1979-08-28 1981-03-11 Ciba-Geigy Ag Polyazathia compounds, process for their preparation, pharmaceutical preparations containing such compounds and use of the latter
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
GR75644B (en) * 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co
GR78245B (en) * 1980-09-12 1984-09-26 Ciba Geigy Ag
US4521413A (en) * 1981-09-14 1985-06-04 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4486586A (en) * 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives

Also Published As

Publication number Publication date
SE470260B (en) 1993-12-20
FI84830C (en) 1992-01-27
GB8721347D0 (en) 1987-10-14
SE8901225D0 (en) 1989-04-06
BE902148A (en) 1985-10-09
IE58403B1 (en) 1993-09-22
ZA852236B (en) 1985-11-27
IT1190353B (en) 1988-02-16
DE3512225A1 (en) 1985-10-17
NL192925B (en) 1998-01-05
YU118987A (en) 1988-10-31
PT80246A (en) 1985-05-01
SE8501680D0 (en) 1985-04-03
YU46213B (en) 1993-05-28
NL192925C (en) 1998-05-07
DD249024A5 (en) 1987-08-26
RU2056425C1 (en) 1996-03-20
JPH0350754B2 (en) 1991-08-02
HU193750B (en) 1987-11-30
NZ211659A (en) 1988-11-29
ES542013A0 (en) 1986-06-16
DD251752A5 (en) 1987-11-25
ES8800949A1 (en) 1987-12-01
KR870002166B1 (en) 1987-12-14
SE8901224D0 (en) 1989-04-06
SE8901226L (en) 1989-04-06
SE8501680L (en) 1985-10-10
LU85840A1 (en) 1985-12-16
ES551550A0 (en) 1987-06-01
GB2194789B (en) 1988-10-12
KR850007424A (en) 1985-12-04
JPH0351716B2 (en) 1991-08-07
FI84830B (en) 1991-10-15
AU580990B2 (en) 1989-02-09
DD236735A5 (en) 1986-06-18
GB2157293B (en) 1988-10-05
SE470259B (en) 1993-12-20
JPH0262557B2 (en) 1990-12-26
AR244694A1 (en) 1993-11-30
IE58408B1 (en) 1993-09-22
OA07985A (en) 1987-01-31
ES557060A0 (en) 1987-12-01
GR850883B (en) 1985-11-25
ES8607318A1 (en) 1986-06-16
NL8501002A (en) 1985-11-01
FR2563832B1 (en) 1989-08-18
MY101940A (en) 1992-02-15
GB8721346D0 (en) 1987-10-14
PT80246B (en) 1987-10-20
JPS615084A (en) 1986-01-10
SU1436882A3 (en) 1988-11-07
GB8508846D0 (en) 1985-05-09
IE850866L (en) 1985-10-09
ES551551A0 (en) 1987-07-01
FI851379L (en) 1985-10-10
GB2194790A (en) 1988-03-16
SE505256C2 (en) 1997-07-21
GB2194790B (en) 1988-10-05
YU46151B (en) 1993-05-28
IT8520267A0 (en) 1985-04-05
HU204277B (en) 1991-12-30
AU610278B2 (en) 1991-05-16
IL74826A0 (en) 1985-07-31
CH669197A5 (en) 1989-02-28
IL74826A (en) 1990-01-18
SU1367858A3 (en) 1988-01-15
GB2194789A (en) 1988-03-16
GB2157293A (en) 1985-10-23
SE8901225L (en) 1989-04-06
SE466205B (en) 1992-01-13
SE8901226D0 (en) 1989-04-06
FI851379A0 (en) 1985-04-04
JPH0357106B2 (en) 1991-08-30
FR2563832A1 (en) 1985-11-08
AT388735B (en) 1989-08-25
JPS61143390A (en) 1986-07-01
CA1276929C (en) 1990-11-27
HUT37622A (en) 1986-01-23
CA1340638C (en) 1999-07-06
SU1375140A3 (en) 1988-02-15
SE8901224L (en) 1989-04-06
YU60085A (en) 1987-12-31
JPS61143387A (en) 1986-07-01
DE3512225C2 (en) 1990-02-22
ATA103985A (en) 1989-01-15
ES8706694A1 (en) 1987-07-01
CA1340672C (en) 1999-07-20
JPS61143391A (en) 1986-07-01
SU1487814A3 (en) 1989-06-15
AU4086285A (en) 1985-10-17
DK155985A (en) 1985-10-10
ES8706155A1 (en) 1987-06-01
DK155985D0 (en) 1985-04-03

Similar Documents

Publication Publication Date Title
AU578391B2 (en) Substituted benzoate ester prodrug derivatives of 3- hydroxymorphinans, intermediates thereto, and processes
AU4982185A (en) Novel 5-amino-4-hydroxyvaleryl derivatives
AU571112B2 (en) Production of mouldings
AU2504188A (en) Novel intermediates of cephalosporin derivatives
AU4673685A (en) Derivatives of methylene-bisphosphonic acid
NZ214691A (en) The preparation of carbapenem derivatives and beta-lactam intermediates
AU552029B2 (en) Derivatives of n-dihydrothiazolyl-3-quinoline
EP0153709A3 (en) Novel cephalosporin derivatives
AU580995B2 (en) 3-fused imidazol-l-yl-methyl cephalosporins
NZ211594A (en) The preparation of certain cephalosporin derivatives
AU558388B2 (en) Production of n-acylphenylalanines
AU576258B2 (en) Purification of tocopherol
PH24371A (en) An intermediate compound of cephalosporin derivatives
AU552478B2 (en) Ester derivatives of oxicams
AU573085B2 (en) Production of monotertiarybutyl toluinediamines
ZA851377B (en) Novel cephalosporin derivatives
AU5106585A (en) Anilide derivatives of substituted arylaceticacids
AU582932B2 (en) Synthesis of nizatidine
AU4354385A (en) Cephalosporin derivatives
AU6514986A (en) Intermediates for the preparation of beta-lactam antibiotics
IL73918A0 (en) Esters of cephalosporin derivatives
AU565648B2 (en) Cephalosporin intermediates
AU557332B2 (en) Cephalosporin derivatives
AU4256489A (en) Intermediates for the manufacture of cephalosporins
AU7028191A (en) Intermediates of peptidylaminodiols